moderna,-inc. - Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,829 +0.67%

DJIA 48,258 +0.73%

Nasdaq 25,057 +0.65%

DAX 23,890 -0.31%

Gold $4,196 +0.16%

Oil $98.06 +1.42%

BTC $72,031 +0.93%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,214 +0.25%

S&P 500 6,829 +0.67%

DJIA 48,258 +0.73%

Nasdaq 25,057 +0.65%

DAX 23,890 -0.31%

Gold $4,196 +0.16%

Oil $98.06 +1.42%

BTC $72,031 +0.93%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,214 +0.25%

moderna,-inc.

Moderna Patent Settlement boosts outlook as premium mRNA vaccine vial symbolizes cleared legal risks

Pharma & Healthcare·Stocks·USA

Moderna Patent Settlement +11.3% Surge: Is the $2.25B Hit Worth the Clarity?

By Maik Kemper • Mar 4, 2026

Moderna Patent Settlement boosts outlook as premium mRNA vaccine vial symbolizes cleared legal risks

Pharma & Healthcare·Stocks·USA

Moderna Patent Settlement +11.3% Surge: Is the $2.25B Hit Worth the Clarity?

By Maik Kemper • Mar 4, 2026

Does Moderna’s billion‑dollar patent peace deal finally clear the runway for its mRNA pipeline—or just cap the upside? Moderna Patent Settlement: Why Wall Street Is…